MARTIN MACKAY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARTIN MACKAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARTIN MACKAY. MARTIN MACKAY is a Senior Vice President in PFIZER INC ($PFE) and a EVP & Global Head of R&D in ALEXION PHARMACEUTICALS INC ($ALXN) and a Director in CHARLES RIVER LABORATORIES INTERNATIONAL INC ($CRL).
Address: PFIZER INC. ATT: CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK 10017 NY
Companies in which MARTIN MACKAY is an Insider
ALEXION PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARTIN MACKAY: EVP & Global Head of R&D
Holdings: 38,883 shares
Current Value: $4,966,137
Latest Transaction: Mar 01 2017
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of MARTIN MACKAY: Director
Holdings: 9,380 shares
Current Value: $774,600
Latest Transaction: May 10 2021
$CRL Market Capitalization: $3.90B
$CRL Previous Close: $82.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PFIZER INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARTIN MACKAY: Senior Vice President
Holdings: 297,581 shares
Current Value: $9,546,398
Latest Transaction: Aug 18 2009
$PFE Market Capitalization: $195.04B
$PFE Previous Close: $32.08
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MARTIN MACKAY
Sentiment: All, ALXN, CRL, PFE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | CRL | CHARLES RIVER LABO ... | MACKAY MARTIN | Director | Option Exercise | A | 342.55 | 1,151 | 394,275 | 1,151 | |
| May 10 2021 | CRL | CHARLES RIVER LABO ... | MACKAY MARTIN | Director | Grant | A | 0.00 | 219 | 0 | 9,599 | 9.4 K to 9.6 K (+2.33 %) |
| May 10 2021 | CRL | CHARLES RIVER LABO ... | MACKAY MARTIN | Director | Grant | A | 0.00 | 355 | 0 | 9,380 | 9 K to 9.4 K (+3.93 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | MACKAY MARTIN | Director | Option Exercise | A | 164.24 | 2,539 | 417,005 | 2,539 | |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | MACKAY MARTIN | Director | Grant | A | 0.00 | 457 | 0 | 9,025 | 8.6 K to 9 K (+5.33 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | MACKAY MARTIN | Director | Grant | A | 0.00 | 741 | 0 | 8,568 | 7.8 K to 8.6 K (+9.47 %) |
| May 23 2019 | CRL | CHARLES RIVER LABO ... | MACKAY MARTIN | Director | Grant | A | 0.00 | 599 | 0 | 7,827 | 7.2 K to 7.8 K (+8.29 %) |